Share buybacks, offerings, activist stakes, shareholder votes and board changes at Japanese companies.
Twelve Tokyo-listed companies disclosed June share-repurchase activity on the same day, and the contrast is stark: Mitani Sekisan bought no stock at all while Kyocera spent ¥29.6bn in a single session.
The number: Resonac will hand shareholders more than 80% of Culasus Chemical, its ¥300.3bn petrochemical unit, on October 1. The catch: the same carve-out triggers a formulaic cut to the conversion price on Resonac's 2028 euro-yen convertible bonds, sized by a five-day trading comparison between the two stocks from September 29 to October 5. The board still has to vote on the spin-off in late August, and the exact price adjustment won't be known until after that trading window closes.
The chemicals group's annual meeting backed current president Yoshiaki Oda as part of an eight-seat board slate, with no other agenda items visible in the disclosure.
The June 26 vote backs four directors and three audit committee directors as the company reports ¥1.30bn in sales, ¥125.47mn in net income and a dividend increase to ¥6.00 a share for the year to March.
The move: Shiseido’s first disclosed use of its April debt programme sets a ¥13bn corporate bond offering against a ¥300bn ceiling that runs until April 2028, with no prior drawdowns listed in the filing.
Up to 5mn shares, or 2.81% of stock, can be repurchased between August 2026 and August 2027, and Kansai Paint says the shares bought will be cancelled, though market conditions could prevent full execution.
The move: Kohjin Bio’s shareholders approved an audit and supervisory committee structure, split the top jobs between a chair and president, and signed off on a ¥10 per share dividend worth ¥51.1mn. Separately, Takahito Nakamura remained disclosed as the controlling shareholder with 53.91% of voting rights.
The move: Shiseido has moved to issue ¥13bn of corporate bonds, the first use of a ¥300bn shelf that became effective in April and runs until April 2028.
The move: Kansai Paint can repurchase up to 5mn shares, or 2.81 per cent of stock excluding treasury shares, between August 2026 and August 2027. The catch: it plans to cancel the repurchased stock, but says some or all orders may go unfilled depending on market conditions.
The move: Kohjin Bio adopted an audit-and-supervisory-committee model and split the top representative role between Takahito Nakamura as chairman and Yuichi Nakamura as president, while a same-day disclosure showed Takahito still controlled 53.91% of voting rights.
The move: Shiseido has filed to issue ¥13bn of corporate bonds under a shelf that runs until April 2028, with the cover page showing a broader ¥300bn programme and no prior offerings under it.
The move: Kansai Paint can repurchase up to 5 million shares, or 2.81 per cent of stock outstanding, from August, and says the stock bought is planned for cancellation, making the programme a cleaner capital-efficiency signal than a standard treasury-stock authorisation.
The ¥19.1mn restricted-stock award uses treasury shares priced at the June 25 close, and transfer limits lift only after executive-officer recipients stay in post through June 30, 2027. For subsidiary directors, the cutoff is the next annual shareholders' meeting date scheduled for June 2027.
Katakura says Zen-Noh and Marubeni exert equivalent influence as shareholders, but disclosed trade flows show far larger business ties to the cooperative federation.
The company appointed its representative director, president and group CEO as chairman of the board effective June 20, and a same-day duties notice says he also keeps risk management and research oversight. That makes the governance change a clear concentration of top roles, not a change of face.
Resona Bank extended the unsecured facility for one year from June 30, but Liberta still has to keep consolidated net assets at 75% or more of the prior-year level and avoid an operating loss. The filing does not disclose how much of the line is drawn.